Welcome!

News Feed Item

Mania Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Mania Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

Mania Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Mania Global Clinical Trials Review, H2, 2014" provides data on the Mania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mania. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Mania 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Mania 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Mania Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
AstraZeneca PLC 32

Clinical Trial Overview of AstraZeneca PLC 32
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Abbott Laboratories 35
Clinical Trial Overview of Abbott Laboratories 35
Johnson & Johnson 36
Clinical Trial Overview of Johnson & Johnson 36
Otsuka Holdings Co., Ltd. 37
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Richter Gedeon Nyrt. 39

Clinical Trial Overview of Richter Gedeon Nyrt. 39
Actavis plc 40
Clinical Trial Overview of Actavis plc 40
Bristol-Myers Squibb Company 41
Clinical Trial Overview of Bristol-Myers Squibb Company 41
Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Top Institutes / Government 43
Massachusetts General Hospital 43
Clinical Trial Overview of Massachusetts General Hospital 43
University of Cincinnati 44
Clinical Trial Overview of University of Cincinnati 44
Mclean Hospital 45
Clinical Trial Overview of Mclean Hospital 45
University of Leipzig 46

Clinical Trial Overview of University of Leipzig 46
Cedars-Sinai Medical Center 47
Clinical Trial Overview of Cedars-Sinai Medical Center 47
University of British Columbia 48
Clinical Trial Overview of University of British Columbia 48
Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
National Institute of Mental Health 50
Clinical Trial Overview of National Institute of Mental Health 50
University of Texas Southwestern Medical Center at Dallas 51
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 51
Mashhad University of Medical Sciences 52
Clinical Trial Overview of Mashhad University of Medical Sciences 52
Five Key Clinical Profiles 53
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116

List of Tables

Mania Therapeutics, Global, Clinical Trials by Region, 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mania Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Mania Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 32
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 35
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 36
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 37

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Richter Gedeon Nyrt., 2014* 39
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 40
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 41
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 42
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 43
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 44
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 45
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014* 46
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2014* 47
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 48

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 49
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 50
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 51
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014* 52

List of Figures

Mania Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Mania Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 115

To order this report: Mania Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"We host and fully manage cloud data services, whether we store, the data, move the data, or run analytics on the data," stated Kamal Shannak, Senior Development Manager, Cloud Data Services, IBM, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Machine Learning helps make complex systems more efficient. By applying advanced Machine Learning techniques such as Cognitive Fingerprinting, wind project operators can utilize these tools to learn from collected data, detect regular patterns, and optimize their own operations. In his session at 18th Cloud Expo, Stuart Gillen, Director of Business Development at SparkCognition, discussed how research has demonstrated the value of Machine Learning in delivering next generation analytics to imp...
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...
The 19th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportuni...
With over 720 million Internet users and 40–50% CAGR, the Chinese Cloud Computing market has been booming. When talking about cloud computing, what are the Chinese users of cloud thinking about? What is the most powerful force that can push them to make the buying decision? How to tap into them? In his session at 18th Cloud Expo, Yu Hao, CEO and co-founder of SpeedyCloud, answered these questions and discussed the results of SpeedyCloud’s survey.
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develo...
SYS-CON Events announced today that MangoApps will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. MangoApps provides modern company intranets and team collaboration software, allowing workers to stay connected and productive from anywhere in the world and from any device.
Large scale deployments present unique planning challenges, system commissioning hurdles between IT and OT and demand careful system hand-off orchestration. In his session at @ThingsExpo, Jeff Smith, Senior Director and a founding member of Incenergy, will discuss some of the key tactics to ensure delivery success based on his experience of the last two years deploying Industrial IoT systems across four continents.
Redis is not only the fastest database, but it is the most popular among the new wave of databases running in containers. Redis speeds up just about every data interaction between your users or operational systems. In his session at 19th Cloud Expo, Dave Nielsen, Developer Advocate, Redis Labs, will share the functions and data structures used to solve everyday use cases that are driving Redis' popularity.
Basho Technologies has announced the latest release of Basho Riak TS, version 1.3. Riak TS is an enterprise-grade NoSQL database optimized for Internet of Things (IoT). The open source version enables developers to download the software for free and use it in production as well as make contributions to the code and develop applications around Riak TS. Enhancements to Riak TS make it quick, easy and cost-effective to spin up an instance to test new ideas and build IoT applications. In addition to...
Predictive analytics tools monitor, report, and troubleshoot in order to make proactive decisions about the health, performance, and utilization of storage. Most enterprises combine cloud and on-premise storage, resulting in blended environments of physical, virtual, cloud, and other platforms, which justifies more sophisticated storage analytics. In his session at 18th Cloud Expo, Peter McCallum, Vice President of Datacenter Solutions at FalconStor, discussed using predictive analytics to mon...
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
In his session at @DevOpsSummit at 19th Cloud Expo, Yoseph Reuveni, Director of Software Engineering at Jet.com, will discuss Jet.com's journey into containerizing Microsoft-based technologies like C# and F# into Docker. He will talk about lessons learned and challenges faced, the Mono framework tryout and how they deployed everything into Azure cloud. Yoseph Reuveni is a technology leader with unique experience developing and running high throughput (over 1M tps) distributed systems with extre...
"We've discovered that after shows 80% if leads that people get, 80% of the conversations end up on the show floor, meaning people forget about it, people forget who they talk to, people forget that there are actual business opportunities to be had here so we try to help out and keep the conversations going," explained Jeff Mesnik, Founder and President of ContentMX, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.